Achieve

ACHV NASDAQ
3.568
+0.168
+4.93%
交易中 15:03 05/21 EDT
开盘
3.340
昨收
3.400
最高
3.683
最低
3.340
成交量
7.58万
成交均量(3M)
172.84万
52周最高
14.31
52周最低
1.045
换手率
1.10%
市值
2,449.43万
分时
5日
1月
3月
1年
5年

评论

暂无数据

相关股票

微牛行情栏目提供Achieve ACHV股票价格,Achieve股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

Achieve Life Sciences, Inc. is a clinical-stage pharmaceutical company engaged in the development and commercialization of cytisine for smoking cessation. The Company’s focus is to address the global smoking health epidemic, which is the leading cause of preventable death and is responsible for nearly six million deaths annually worldwide. Cytisine is an established 25 day smoking cessation treatment that has been approved and marketed in Central and Eastern Europe by a third party for over 20 years under the brand name TabexTM. As of December 2016, it is estimated that over 21 million people have used cytisine to help combat nicotine addiction, including over 2,000 patients in investigator-conducted, Phase III clinical trials in Europe and New Zealand.
展开 >

最近浏览

名称
价格
涨跌幅